101 results
8-K
EX-99.1
ALDX
Aldeyra Therapeutics Inc
21 Jun 23
Other Events
4:25pm
for PVRL, and Inbound Requests for ADX-2191, Expanded Access Program Planned to be Discussed with FDA
LEXINGTON, Mass.--(BUSINESS WIRE)--June 21, 2023 … formulations, we look forward to discussing with the FDA the potential for making ADX-2191 available to PVRL patients under an Expanded Access Program.”
PVRL
DEFA14A
ALDX
Aldeyra Therapeutics Inc
22 Apr 19
Additional proxy soliciting materials
4:10pm
you to access and review all of the important information contained in the proxy materials before voting.
See the reverse side of this notice … to obtain proxy materials and voting instructions.
— Before You Vote —
How to Access the Proxy Materials
Proxy Materials Available to VIEW or RECEIVE
DEFA14A
ALDX
Aldeyra Therapeutics Inc
25 Apr 18
Additional proxy soliciting materials
5:25pm
to access and review all of the important information contained in the proxy materials before voting.
See the reverse side of this notice to obtain proxy … materials and voting instructions.
— Before You Vote —
How to Access the Proxy Materials
Proxy Materials Available to VIEW or RECEIVE:
NOTICE
DEFA14A
ALDX
Aldeyra Therapeutics Inc
27 Apr 20
Additional proxy soliciting materials
5:21pm
. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side). We encourage you to access and review … and voting instructions. Broadridge Internal Use Only Job # Envelope # Sequence # # of # Sequence # BARCODE 1 OF 2 12 15
Before You Vote How to Access
8-K
EX-99.2
yytnxhd dy1bp9dbq5
25 Sep 18
Aldeyra Therapeutics Announces Positive Mesothelioma Investigator-Sponsored Clinical Trial Results
8:17am
8-K
ik5r51fho 2f2
20 Jan 15
Aldeyra Therapeutics Announces $2.0 Million Private Placement
12:00am
8-K
0l8 o5oaeogtcc4
13 Jan 15
Aldeyra Therapeutics Announces $7.79 Million Private Placement
12:00am
8-K
EX-99.2
z4pc4da m45
2 Mar 15
Regulation FD Disclosure
12:00am